Adze1.C

AXP000063.1 · Oncolytic virus

Platform
adenovirus
Originator
Adze Biotechnology
Sponsor
Adze Biotechnology Australia

Names

NameTypeSource
Adze1.Cpreferred name, codecurator, ctgov

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus (serotype not reported)
Replication
conditionally replicating
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT07086105A Study to Evaluate Adze1.C in Participants With Metastatic MelanomaRecruitingPhase 12025-10-012027-10-0130Metastatic Melanoma

Recent changes

No changes recorded in its trials yet.

Notes

Oncolytic adenovirus, trial NCT07086105 (Australia). Construct not described in the registration.

How to cite

Adze1.C (AXP000063.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000063.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.